Determination and kinetics of antibody response to Candida albicans in ulcerative colitis

F. Nagy, Z. Zsenasi, E. Szollosy, I. Kiss, V. Varro

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Levels of antibody against the mannan component of Candida albicans cell wall were determined and followed in 57 ulcerative colitis patients. The appearance of higher titers suggests an intermittent (benign) clinical course of the disease. Lower titer values at repeated checks are associated with a continuous (severe) clinical course. Our data suggest that Candida albicans antibody titer values may be used as an indicator of the clinical outcome of ulcerative colitis.

Original languageEnglish
Pages (from-to)182-184
Number of pages3
JournalHepato-Gastroenterology
Volume36
Issue number4
Publication statusPublished - 1989

Fingerprint

Candida albicans
Ulcerative Colitis
Antibody Formation
Mannans
Antibodies
Cell Wall

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Determination and kinetics of antibody response to Candida albicans in ulcerative colitis. / Nagy, F.; Zsenasi, Z.; Szollosy, E.; Kiss, I.; Varro, V.

In: Hepato-Gastroenterology, Vol. 36, No. 4, 1989, p. 182-184.

Research output: Contribution to journalArticle

Nagy, F, Zsenasi, Z, Szollosy, E, Kiss, I & Varro, V 1989, 'Determination and kinetics of antibody response to Candida albicans in ulcerative colitis', Hepato-Gastroenterology, vol. 36, no. 4, pp. 182-184.
Nagy, F. ; Zsenasi, Z. ; Szollosy, E. ; Kiss, I. ; Varro, V. / Determination and kinetics of antibody response to Candida albicans in ulcerative colitis. In: Hepato-Gastroenterology. 1989 ; Vol. 36, No. 4. pp. 182-184.
@article{0fdd2364572e4a5da240a57369661164,
title = "Determination and kinetics of antibody response to Candida albicans in ulcerative colitis",
abstract = "Levels of antibody against the mannan component of Candida albicans cell wall were determined and followed in 57 ulcerative colitis patients. The appearance of higher titers suggests an intermittent (benign) clinical course of the disease. Lower titer values at repeated checks are associated with a continuous (severe) clinical course. Our data suggest that Candida albicans antibody titer values may be used as an indicator of the clinical outcome of ulcerative colitis.",
author = "F. Nagy and Z. Zsenasi and E. Szollosy and I. Kiss and V. Varro",
year = "1989",
language = "English",
volume = "36",
pages = "182--184",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "4",

}

TY - JOUR

T1 - Determination and kinetics of antibody response to Candida albicans in ulcerative colitis

AU - Nagy, F.

AU - Zsenasi, Z.

AU - Szollosy, E.

AU - Kiss, I.

AU - Varro, V.

PY - 1989

Y1 - 1989

N2 - Levels of antibody against the mannan component of Candida albicans cell wall were determined and followed in 57 ulcerative colitis patients. The appearance of higher titers suggests an intermittent (benign) clinical course of the disease. Lower titer values at repeated checks are associated with a continuous (severe) clinical course. Our data suggest that Candida albicans antibody titer values may be used as an indicator of the clinical outcome of ulcerative colitis.

AB - Levels of antibody against the mannan component of Candida albicans cell wall were determined and followed in 57 ulcerative colitis patients. The appearance of higher titers suggests an intermittent (benign) clinical course of the disease. Lower titer values at repeated checks are associated with a continuous (severe) clinical course. Our data suggest that Candida albicans antibody titer values may be used as an indicator of the clinical outcome of ulcerative colitis.

UR - http://www.scopus.com/inward/record.url?scp=0024428405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024428405&partnerID=8YFLogxK

M3 - Article

C2 - 2680855

AN - SCOPUS:0024428405

VL - 36

SP - 182

EP - 184

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 4

ER -